258 related articles for article (PubMed ID: 7504889)
1. Tumor necrosis factor activates human endothelial cells through the p55 tumor necrosis factor receptor but the p75 receptor contributes to activation at low tumor necrosis factor concentration.
Slowik MR; De Luca LG; Fiers W; Pober JS
Am J Pathol; 1993 Dec; 143(6):1724-30. PubMed ID: 7504889
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor alpha induces endothelial galactosyl transferase activity and verocytotoxin receptors. Role of specific tumor necrosis factor receptors and protein kinase C.
van de Kar NC; Kooistra T; Vermeer M; Lesslauer W; Monnens LA; van Hinsbergh VW
Blood; 1995 Feb; 85(3):734-43. PubMed ID: 7530504
[TBL] [Abstract][Full Text] [Related]
3. The p55 tumor necrosis factor receptor (CD120a) induces endothelin-1 synthesis in endothelial and epithelial cells.
Lees DM; Pallikaros Z; Corder R
Eur J Pharmacol; 2000 Feb; 390(1-2):89-94. PubMed ID: 10708710
[TBL] [Abstract][Full Text] [Related]
4. Activation of the TNF alpha-p55 receptor induces myocyte proliferation and modulates agonist-evoked calcium transients in cultured human tracheal smooth muscle cells.
Amrani Y; Panettieri RA; Frossard N; Bronner C
Am J Respir Cell Mol Biol; 1996 Jul; 15(1):55-63. PubMed ID: 8679222
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor (TNF)-alpha-induced interleukin-8 in human blood cultures discriminates neutralization by the p55 and p75 TNF soluble receptors.
Frishman JI; Edwards CK; Sonnenberg MG; Kohno T; Cohen AM; Dinarello CA
J Infect Dis; 2000 Dec; 182(6):1722-30. PubMed ID: 11069245
[TBL] [Abstract][Full Text] [Related]
6. Functional activities of receptors for tumor necrosis factor-alpha on human vascular endothelial cells.
Paleolog EM; Delasalle SA; Buurman WA; Feldmann M
Blood; 1994 Oct; 84(8):2578-90. PubMed ID: 7919375
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor alpha (TNF-alpha) receptor-II is required for TNF-alpha-induced leukocyte-endothelial interaction in vivo.
Chandrasekharan UM; Siemionow M; Unsal M; Yang L; Poptic E; Bohn J; Ozer K; Zhou Z; Howe PH; Penn M; DiCorleto PE
Blood; 2007 Mar; 109(5):1938-44. PubMed ID: 17068152
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75.
Sheehan KC; Pinckard JK; Arthur CD; Dehner LP; Goeddel DV; Schreiber RD
J Exp Med; 1995 Feb; 181(2):607-17. PubMed ID: 7836916
[TBL] [Abstract][Full Text] [Related]
9. p55 and p75 tumor necrosis factor receptors are expressed and mediate common functions in synovial fibroblasts and other fibroblasts.
Butler DM; Feldmann M; Di Padova F; Brennan FM
Eur Cytokine Netw; 1994; 5(5):441-8. PubMed ID: 7880974
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a spontaneously transformed human endothelial cell line.
Cockerill GW; Meyer G; Noack L; Vadas MA; Gamble JR
Lab Invest; 1994 Oct; 71(4):497-509. PubMed ID: 7526034
[TBL] [Abstract][Full Text] [Related]
11. IFN-gamma enhances endothelial activation induced by tumor necrosis factor but not IL-1.
Doukas J; Pober JS
J Immunol; 1990 Sep; 145(6):1727-33. PubMed ID: 1697308
[TBL] [Abstract][Full Text] [Related]
12. p55 and p75 tumor necrosis factor receptor expression on human glioblastoma cells.
Kato T; Sawamura Y; Tada M; Sakuma S; Sudo M; Abe H
Neurol Med Chir (Tokyo); 1995 Aug; 35(8):567-74. PubMed ID: 7566386
[TBL] [Abstract][Full Text] [Related]
13. Invasive human T lymphoma cells produce a novel factor that upregulates expression of adhesion molecules on endothelial cells.
Totsuka T; Tanimoto H; Yamaguchi T; Inoue H; Saito I; Miyasaka N
Exp Hematol; 1993 Nov; 21(12):1544-9. PubMed ID: 7691638
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of eosinophilic inflammation in allergen-challenged TNF receptor p55/p75--and TNF receptor p55-deficient mice.
Broide DH; Stachnick G; Castaneda D; Nayar J; Sriramarao P
Am J Respir Cell Mol Biol; 2001 Mar; 24(3):304-11. PubMed ID: 11245629
[TBL] [Abstract][Full Text] [Related]
15. Tumour necrosis factor induction of ELAM-1 and ICAM-1 on human umbilical vein endothelial cells--analysis of tumour necrosis factor-receptor interactions.
Thorp KM; Southern C; Bird IN; Matthews N
Cytokine; 1992 Jul; 4(4):313-9. PubMed ID: 1381227
[TBL] [Abstract][Full Text] [Related]
16. TNF receptor p55 plays a major role in centrally mediated increases of serum IL-6 and corticosterone after intracerebroventricular injection of TNF.
Benigni F; Faggioni R; Sironi M; Fantuzzi G; Vandenabeele P; Takahashi N; Sacco S; Fiers W; Buurman WA; Ghezzi P
J Immunol; 1996 Dec; 157(12):5563-8. PubMed ID: 8955207
[TBL] [Abstract][Full Text] [Related]
17. Ligand-induced formation of p55 and p75 tumor necrosis factor receptor heterocomplexes on intact cells.
Pinckard JK; Sheehan KC; Schreiber RD
J Biol Chem; 1997 Apr; 272(16):10784-9. PubMed ID: 9099731
[TBL] [Abstract][Full Text] [Related]
18. Distinct roles of the two tumor necrosis factor (TNF) receptors in modulating TNF and lymphotoxin alpha effects.
Medvedev AE; Espevik T; Ranges G; Sundan A
J Biol Chem; 1996 Apr; 271(16):9778-84. PubMed ID: 8621658
[TBL] [Abstract][Full Text] [Related]
19. Evidence for exclusive role in signalling of tumour necrosis factor p55 receptor and a potentiating function of p75 receptor on human endothelial cells.
Leeuwenberg JF; van Tits LJ; Jeunhomme TM; Buurman WA
Cytokine; 1995 Jul; 7(5):457-62. PubMed ID: 7578984
[TBL] [Abstract][Full Text] [Related]
20. Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1.
Pober JS; Slowik MR; De Luca LG; Ritchie AJ
J Immunol; 1993 Jun; 150(11):5114-23. PubMed ID: 7684420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
